wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47735319-2ADDD812-0FCA-4B9F-967A-3BFE803B2FDA
Q47735319-2ADDD812-0FCA-4B9F-967A-3BFE803B2FDA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47735319-2ADDD812-0FCA-4B9F-967A-3BFE803B2FDA
EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs.
P2860
Q47735319-2ADDD812-0FCA-4B9F-967A-3BFE803B2FDA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47735319-2ADDD812-0FCA-4B9F-967A-3BFE803B2FDA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1508bcc081285aff337af9b672115daff1928bfe
P2860
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer.